Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerri Basile

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Transplantation|July 18, 2024
The Effects of COVID-19 in Kidney Transplantation: Evidence From Tissue PathologyBrian J Nankivell, Chow P'ng, Thomas Tran, et al.
Frontiers in Microbiology|June 6, 2022
SARS-CoV-2 Within-Host and <i>in vitro</i> Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and <i>in vitro</i> CultureJessica E Agius, Jessica C Johnson-Mackinnon, Winkie Fong, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2023
Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severityAnnaleise R Howard-Jones, Alicia Arnott, Jenny Draper, et al.
Open Forum Infectious Diseases|September 29, 2020
The Antibody Response to SARS-CoV-2 InfectionLinda Hueston, Jen Kok, Ayla Guibone, et al.
Viruses|September 27, 2025
Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 VaccineKerri Basile, Jessica E Agius, Winkie Fong, et al.
Emerging Infectious Diseases|December 19, 2018
Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United StatesEveliina Karelehto, Lieke Brouwer, Kimberley Benschop, et al.
Microbiology Spectrum|November 15, 2023
A laboratory framework for ongoing optimization of amplification-based genomic surveillance programsConnie Lam, Jessica Johnson-Mackinnon, Kerri Basile, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2020
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019Kerri Basile, Kenneth McPhie, Ian Carter, et al.
Frontiers in Microbiology|February 6, 2026
Emerging fluconazole-resistant <i>Candida parapsilosis</i> in Australia: a case cluster and insights into the genetic diversity of this speciesManoshi Perera, Winkie Fong, Rose Haywood, et al.
Viruses|September 23, 2022
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 VaccineKerri Basile, Rebecca J Rockett, Kenneth McPhie, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Transplantation|July 18, 2024
The Effects of COVID-19 in Kidney Transplantation: Evidence From Tissue PathologyBrian J Nankivell, Chow P'ng, Thomas Tran, et al.
Frontiers in Microbiology|June 6, 2022
SARS-CoV-2 Within-Host and <i>in vitro</i> Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and <i>in vitro</i> CultureJessica E Agius, Jessica C Johnson-Mackinnon, Winkie Fong, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2023
Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severityAnnaleise R Howard-Jones, Alicia Arnott, Jenny Draper, et al.
Open Forum Infectious Diseases|September 29, 2020
The Antibody Response to SARS-CoV-2 InfectionLinda Hueston, Jen Kok, Ayla Guibone, et al.
Viruses|September 27, 2025
Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 VaccineKerri Basile, Jessica E Agius, Winkie Fong, et al.
Emerging Infectious Diseases|December 19, 2018
Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United StatesEveliina Karelehto, Lieke Brouwer, Kimberley Benschop, et al.
Microbiology Spectrum|November 15, 2023
A laboratory framework for ongoing optimization of amplification-based genomic surveillance programsConnie Lam, Jessica Johnson-Mackinnon, Kerri Basile, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2020
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019Kerri Basile, Kenneth McPhie, Ian Carter, et al.
Frontiers in Microbiology|February 6, 2026
Emerging fluconazole-resistant <i>Candida parapsilosis</i> in Australia: a case cluster and insights into the genetic diversity of this speciesManoshi Perera, Winkie Fong, Rose Haywood, et al.
Viruses|September 23, 2022
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 VaccineKerri Basile, Rebecca J Rockett, Kenneth McPhie, et al.
Pageof 3